137 related articles for article (PubMed ID: 21045363)
1. Disseminated cryptococcosis and fluconazole resistant oral candidiasis in a patient with acquired immunodeficiency syndrome (AIDS).
Kothavade RJ; Oberai CM; Valand AG; Panthaki MH
J Infect Dev Ctries; 2010 Oct; 4(10):674-8. PubMed ID: 21045363
[TBL] [Abstract][Full Text] [Related]
2. Disseminated cryptococcosis in an AIDS patient caused by a canavanine-resistant strain of Cryptococcus neoformans var. grubii.
Khan ZU; Al-Anezi AA; Chandy R; Xu J
J Med Microbiol; 2003 Mar; 52(Pt 3):271-275. PubMed ID: 12621094
[TBL] [Abstract][Full Text] [Related]
3. Response to therapy in patients with cryptococcosis and AIDS: Association with in vitro susceptibility to fluconazole.
Agudelo CA; Muñoz C; Ramírez A; Tobón AM; de Bedout Bact C; Cano LE; Restrepo A
Rev Iberoam Micol; 2015; 32(4):214-20. PubMed ID: 25637338
[TBL] [Abstract][Full Text] [Related]
4. Oral fluconazole as suppressive therapy of disseminated cryptococcosis in patients with acquired immunodeficiency syndrome.
Sugar AM; Saunders C
Am J Med; 1988 Oct; 85(4):481-9. PubMed ID: 2845779
[TBL] [Abstract][Full Text] [Related]
5. Invasive fungal infection by Cryptococcus neoformans var. grubii with bone marrow and meningeal involvement in a HIV-infected patient: a case report.
Vechi HT; Theodoro RC; de Oliveira AL; Gomes RMODS; Soares RDA; Freire MG; Bay MB
BMC Infect Dis; 2019 Mar; 19(1):220. PubMed ID: 30832607
[TBL] [Abstract][Full Text] [Related]
6. [Profound mycoses in AIDS in Abidjan (Côte d'Ivoire)].
Eholie SP; N'gbocho L; Bissagnene E; Coulibaly M; Ehui E; Kra O; Assoumou A; Aoussi E; Kadio A
Bull Soc Pathol Exot; 1997; 90(5):307-11. PubMed ID: 9507758
[TBL] [Abstract][Full Text] [Related]
7. Antifungal susceptibilities of clinical isolates of Candida species, Cryptococcus neoformans, and Aspergillus species from Taiwan: surveillance of multicenter antimicrobial resistance in Taiwan program data from 2003.
Hsueh PR; Lau YJ; Chuang YC; Wan JH; Huang WK; Shyr JM; Yan JJ; Yu KW; Wu JJ; Ko WC; Yang YC; Liu YC; Teng LJ; Liu CY; Luh KT
Antimicrob Agents Chemother; 2005 Feb; 49(2):512-7. PubMed ID: 15673726
[TBL] [Abstract][Full Text] [Related]
8. Activity of VT-1129 against Cryptococcus neoformans clinical isolates with high fluconazole MICs.
Nielsen K; Vedula P; Smith KD; Meya DB; Garvey EP; Hoekstra WJ; Schotzinger RJ; Boulware DR
Med Mycol; 2017 Jun; 55(4):453-456. PubMed ID: 27664991
[TBL] [Abstract][Full Text] [Related]
9. Oral fluconazole therapy for patients with acquired immunodeficiency syndrome and cryptococcosis: experience with 22 patients.
Stern JJ; Hartman BJ; Sharkey P; Rowland V; Squires KE; Murray HW; Graybill JR
Am J Med; 1988 Oct; 85(4):477-80. PubMed ID: 2845778
[TBL] [Abstract][Full Text] [Related]
10. Molecular epidemiology and antifungal susceptibility of Cryptococcus neoformans isolates from Ugandan AIDS patients.
Pfaller M; Zhang J; Messer S; Tumberland M; Mbidde E; Jessup C; Ghannoum M
Diagn Microbiol Infect Dis; 1998 Nov; 32(3):191-9. PubMed ID: 9884835
[TBL] [Abstract][Full Text] [Related]
11. In vitro antifungal activities of amphotericin B, 5-fluorocytosine, fluconazole and itraconazole against Cryptococcus neoformans isolated from cerebrospinal fluid and blood from patients in Serbia.
Trpković A; Pekmezović M; Barać A; Crnčević Radović L; Arsić Arsenijević V
J Mycol Med; 2012 Sep; 22(3):243-8. PubMed ID: 23518082
[TBL] [Abstract][Full Text] [Related]
12. Molecular identification, antifungal resistance and virulence of Cryptococcus neoformans and Cryptococcus deneoformans isolated in Seville, Spain.
Gago S; Serrano C; Alastruey-Izquierdo A; Cuesta I; Martín-Mazuelos E; Aller AI; Gómez-López A; Mellado E
Mycoses; 2017 Jan; 60(1):40-50. PubMed ID: 27633849
[TBL] [Abstract][Full Text] [Related]
13. Fluconazole susceptibility testing of Cryptococcus neoformans: comparison of two broth microdilution methods and clinical correlates among isolates from Ugandan AIDS patients.
Jessup CJ; Pfaller MA; Messer SA; Zhang J; Tumberland M; Mbidde EK; Ghannoum MA
J Clin Microbiol; 1998 Oct; 36(10):2874-6. PubMed ID: 9738036
[TBL] [Abstract][Full Text] [Related]
14. Berberine Antifungal Activity in Fluconazole-Resistant Pathogenic Yeasts: Action Mechanism Evaluated by Flow Cytometry and Biofilm Growth Inhibition in Candida spp.
da Silva AR; de Andrade Neto JB; da Silva CR; Campos Rde S; Costa Silva RA; Freitas DD; do Nascimento FB; de Andrade LN; Sampaio LS; Grangeiro TB; Magalhães HI; Cavalcanti BC; de Moraes MO; Nobre Júnior HV
Antimicrob Agents Chemother; 2016 Jun; 60(6):3551-7. PubMed ID: 27021328
[TBL] [Abstract][Full Text] [Related]
15. Disseminated cryptococcosis in a patient with nephrotic syndrome.
Qadir F; Manzoor K; Ahmed E
Indian J Med Microbiol; 2006 Apr; 24(2):141-3. PubMed ID: 16687870
[TBL] [Abstract][Full Text] [Related]
16. MDR1 overexpression combined with ERG11 mutations induce high-level fluconazole resistance in Candida tropicalis clinical isolates.
Jin L; Cao Z; Wang Q; Wang Y; Wang X; Chen H; Wang H
BMC Infect Dis; 2018 Apr; 18(1):162. PubMed ID: 29631565
[TBL] [Abstract][Full Text] [Related]
17. Increasing trend of fluconazole-non-susceptible Cryptococcus neoformans in patients with invasive cryptococcosis: a 12-year longitudinal study.
Chen YC; Chang TY; Liu JW; Chen FJ; Chien CC; Lee CH; Lu CH
BMC Infect Dis; 2015 Jul; 15():277. PubMed ID: 26194004
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of alcohol-based and alcohol-free melaleuca oral solution for the treatment of fluconazole-refractory oropharyngeal candidiasis in patients with AIDS.
Vazquez JA; Zawawi AA
HIV Clin Trials; 2002; 3(5):379-85. PubMed ID: 12407487
[TBL] [Abstract][Full Text] [Related]
19. Antifungal susceptibility of clinical and environmental Cryptococcus neoformans and Cryptococcus gattii isolates in Jabalpur, a city of Madhya Pradesh in Central India.
Gutch RS; Nawange SR; Singh SM; Yadu R; Tiwari A; Gumasta R; Kavishwar A
Braz J Microbiol; 2015; 46(4):1125-33. PubMed ID: 26691471
[TBL] [Abstract][Full Text] [Related]
20. In-vitro activity of dicationic aromatic compounds and fluconazole against Cryptococcus neoformans and Candida spp.
Del Poeta M; Bixel AS; Barchiesi F; Tidwell RR; Boykin D; Scalise G; Perfect JR
J Antimicrob Chemother; 1999 Aug; 44(2):223-8. PubMed ID: 10473229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
